Experts Praise Africa’s COVID-19 Response; India, Pakistan Increase Remdesivir Production; New Virus Hospital Opens In Yemen; NIH Communications Employee Departs After Anonymous Posts Attacking U.S. Health Officials
AP: As rich nations struggle, Africa’s virus response is praised (Anna, 9/22).
Thomson Reuters Foundation: Coronavirus rumors and regulations mar Burkina Faso’s malaria fight (Mednick, 9/21).
Financial Times: India and Pakistan ramp up remdesivir production under Gilead deal (Findlay, 9/21).
Reuters: Philippines’ Duterte eases overseas travel ban on health workers (Lema/Morales, 9/21).
Washington Post: As infections ebb, Japan hopes it has cracked the covid code on coexisting with the virus (Denyer, 9/19).
AP: Poland seeks more flu vaccines amid shortage during pandemic (Gera, 9/22).
Reuters: Exclusive: E.U. in early talks with Italy’s ReiThera over potential vaccine supply deal — source (Parodi et al., 9/21).
Washington Post: Britain could face 50,000 coronavirus cases per day by mid-October, top government scientists warn (Adam, 9/21).
WIRED: Could a Century-Old TB Shot Protect Against Other Respiratory Diseases? (Vaidyanathan, 9/21).
The Guardian: Covid warnings ring out as Latin America bids to return to normality (Daniels et al., 9/19).
AP: Yemen gets new virus hospital after other facilities close (Olsen, 9/22).
Daily Beast: A Notorious COVID Troll Actually Works for Dr. Fauci’s Agency (Markay, 9/21).
New York Times: NIH Official Departs After Anonymous Posts Attacking Public Health Leaders (Montague, 9/21).
PRI: Atul Gawande: With right ‘political environment,’ U.S. can control the coronavirus (Hackel, 9/21).
STAT: Joe Biden’s campaign-trail challenge: Casting doubt on a Trump vaccine without fueling broader vaccine skepticism (Facher, 9/22).